Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
CALL
Polaris
PII
$3.95B
| $12.1M | ﹤0.01% |
121,900
-10,800
| -8% | -$1.12M |
|
2352
PUT
Sony
SONY
$142B
| $12.1M | ﹤0.01% |
738,500
-26,500
| -3% | -$469K |
|
|
PPL
2353
CALL
PPL Corp
PPL
$27.1B
| $12.1M | ﹤0.01% |
444,800
-62,200
| -12% | -$1.79M |
|
2354
CALL
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$89.9M
| $12.1M | ﹤0.01% |
187,200
+119,500
| +177% | +$10.9M |
|
2355
Comstock Resources
CRK
$4.13B
| $12.1M | ﹤0.01% |
998,529
+803,407
| +412% | +$13.3M |
|
|
TRML
2356
DELISTED
Tourmaline Bio
TRML
| $12.1M | ﹤0.01% |
267,247
+888
| +0.3% | +$70.1K |
|
|
MYOV
2357
DELISTED
Myovant Sciences Ltd.
MYOV
| $12M | ﹤0.01% |
968,696
+318,407
| +49% | +$3.51M |
|
2358
CALL
State Street Communication Services Select Sector SPDR ETF
XLC
$22.9B
| $12M | ﹤0.01% |
221,500
+19,300
| +10% | +$1.16M |
|
2359
PUT
JB Hunt Transport Services
JBHT
$26.3B
| $12M | ﹤0.01% |
76,300
-8,900
| -10% | -$1.51M |
|
2360
RenaissanceRe
RNR
$13.4B
| $12M | ﹤0.01% |
76,765
-201,049
| -72% | -$30.4M |
|
2361
CALL
Fastenal
FAST
$58.5B
| $12M | ﹤0.01% |
480,800
+13,000
| +3% | +$350K |
|
2362
Hertz
HTZ
$798M
| $12M | ﹤0.01% |
757,218
-386,683
| -34% | -$7.63M |
|
2363
CALL
iShares Russell 1000 Value ETF
IWD
$84.2B
| $12M | ﹤0.01% |
82,700
-53,700
| -39% | -$8.4M |
|
2364
Outset Medical
OM
$84.8M
| $12M | ﹤0.01% |
53,733
-1,553
| -3% | -$668K |
|
|
GSQB
2365
DELISTED
G Squared Ascend II Inc.
GSQB
| $12M | ﹤0.01% |
1,220,291
| – | – |
|
2366
Huntington Ingalls Industries
HII
$12.9B
| $12M | ﹤0.01% |
54,944
-443,033
| -89% | -$93.6M |
|
|
PANA
2367
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
| $11.9M | ﹤0.01% |
1,225,172
+2,741
| +0.2% | +$26.7K |
|
2368
CALL
Southern Copper
SCCO
$156B
| $11.9M | ﹤0.01% |
261,670
+46,832
| +22% | +$2.67M |
|
2369
PUT
Constellium
CSTM
$4.01B
| $11.9M | ﹤0.01% |
903,200
+831,100
| +1,153% | +$13.3M |
|
2370
PUT
Canadian Pacific Kansas City
CP
$82.2B
| $11.9M | ﹤0.01% |
170,604
+69,500
| +69% | +$5.03M |
|
2371
CALL
Boyd Gaming
BYD
$6.11B
| $11.9M | ﹤0.01% |
239,400
+62,700
| +35% | +$3.63M |
|
2372
Madison Square Garden
MSGS
$9.8B
| $11.9M | ﹤0.01% |
78,844
+36,792
| +87% | +$5.97M |
|
|
GAP
2373
CALL
The Gap Inc
GAP
$7.42B
| $11.9M | ﹤0.01% |
1,444,400
+298,900
| +26% | +$3.46M |
|
2374
Immuneering
IMRX
$327M
| $11.9M | ﹤0.01% |
2,199,209
+39,777
| +2% | +$212K |
|
|
SNCY
2375
DELISTED
Sun Country Airlines
SNCY
| $11.9M | ﹤0.01% |
648,573
-260,287
| -29% | -$6.09M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.